Literature DB >> 29395683

Three synchronous malignancies in a patient with DICER1 syndrome.

Diana J Moke1, Stefanie M Thomas2, Matthew C Hiemenz3, Ali Nael4, Kasper Wang5, Nick Shillingford3, Jaclyn A Biegel3, Leo Mascarenhas6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29395683     DOI: 10.1016/j.ejca.2017.12.021

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Expanding the spectrum of dicer1-associated sarcomas.

Authors:  Mikako Warren; Matthew C Hiemenz; Ryan Schmidt; Jared Shows; Jennifer Cotter; Stephanie Toll; David M Parham; Jaclyn A Biegel; Leo Mascarenhas; Rachana Shah
Journal:  Mod Pathol       Date:  2019-09-19       Impact factor: 7.842

2.  Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma.

Authors:  Leanne de Kock; Ju-Yoon Yoon; Blaise A Clarke; William D Foulkes; Maria Apellaniz-Ruiz; Dylan Pelletier; W Glenn McCluggage; Colin J R Stewart; Brendan C Dickson; Marjan Rouzbahman
Journal:  Mod Pathol       Date:  2020-01-03       Impact factor: 7.842

Review 3.  Spectrum of DICER1 Germline Pathogenic Variants in Ovarian Sertoli-Leydig Cell Tumor.

Authors:  Elisa De Paolis; Rosa Maria Paragliola; Paola Concolino
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

4.  Ovarian Sertoli-Leydig Cell Tumor, Multinodular Goiter, Cystic Nephromas and DICER1 Mutations: Case Report and Literature Review.

Authors:  Yanglin Ni; Xuan Zhou; Ling Wu; Ping Wu; Ying Liu; Yinnan Li; Li Cai; Xueshu Fu; Chunhua Zhang
Journal:  Pharmgenomics Pers Med       Date:  2021-08-03

5.  Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study.

Authors:  Jacob J Henderson; Anirban Das; Daniel A Morgenstern; Sumedha Sudhaman; Vanessa Bianchi; Jill Chung; Logine Negm; Melissa Edwards; David E Kram; Michael Osborn; Cynthia Hawkins; Eric Bouffet; Yoon-Jae Cho; Uri Tabori
Journal:  JCO Precis Oncol       Date:  2022-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.